<?xml version="1.0" ?>
<document id="80637e7403f730cb2e22a4af53fade48a1e42a87">
  <chunk id="80637e7403f730cb2e22a4af53fade48a1e42a87.c0" text="The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs"/>
  <chunk id="80637e7403f730cb2e22a4af53fade48a1e42a87.c1" text="Background: Enterovirus 71 (EV71) is a highly infectious agent that plays an etiological role in hand, foot, and mouth disease. It is associated with severe neurological complications and has caused significant mortalities in recent large-scale outbreaks. Currently, no effective vaccine or specific clinical therapy is available against EV71.">
    <entity charOffset="89-93" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c1.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
  </chunk>
  <chunk id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2" text="Methods: Unmodified 21 nucleotide small interfering RNAs (siRNAs) and classic 2 0 -modified (2 0 -O-methylation or 2 0 -fluoro modification) siRNAs were designed to target highly conserved 5 0 untranslated region (UTR) of the EV71 genome and employed as anti-EV71 agents. Real-time TaqMan RT-PCR, western blot analysis and plaque assays were carried out to evaluate specific viral inhibition by the siRNAs. Results: Transfection of rhabdomyosarcoma (RD) cells with siRNAs targeting the EV71 genomic 5 0 UTR significantly delayed and alleviated the cytopathic effects of EV71 infection, increased cell viability in EV71-infected RD cells. The inhibitory effect on EV71 replication was sequence-specific and dosage-dependent, with significant corresponding decreases in viral RNA, VP1 protein and viral titer. Appropriate 2 0 -modified siRNAs exhibited similar RNA interference (RNAi) activity with dramatically increased serum stability in comparison with unmodified counterparts.">
    <entity charOffset="23-33" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e0" ontology_id="CHEBI_36976" text="nucleotide" type="chemical"/>
    <entity charOffset="432-448" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e1" ontology_id="DOID_3247" text="rhabdomyosarcoma" type="disease"/>
    <entity charOffset="774-777" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e2" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="783-790" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e3" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="859-862" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e4" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <pair e1="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e0" e2="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e1" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.p0" relation="true"/>
    <pair e1="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e1" e2="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e2" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.p1" relation="true"/>
    <pair e1="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e1" e2="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e3" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.p2" relation="true"/>
    <pair e1="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e1" e2="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.e4" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c2.p3" relation="true"/>
  </chunk>
  <chunk id="80637e7403f730cb2e22a4af53fade48a1e42a87.c3" text="Conclusion: Sequences were identified within the highly conserved 5 0 UTR that can be targeted to effectively inhibit EV71 replication through RNAi strategies. Appropriate 2 0 -modified siRNAs provide a promising approach to optimizing siRNAs to overcome barriers on RNAi-based antiviral therapies for broader administration.">
    <entity charOffset="278-287" id="80637e7403f730cb2e22a4af53fade48a1e42a87.c3.e0" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
  </chunk>
</document>
